Literature DB >> 3999084

Sublingual isoprenaline in treatment of primary pulmonary hypertension: discussion paper.

J F Ackroyd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3999084      PMCID: PMC1289778          DOI: 10.1177/014107688507800611

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  24 in total

1.  Primary pulmonary hypertension favorable effect of isoproterenol.

Authors:  U R Shettigar; H N Hultgren; M Specter; R Martin; D H Davies
Journal:  N Engl J Med       Date:  1976-12-16       Impact factor: 91.245

2.  Isoprenaline resistance and the use of pressurised aerosols in asthma.

Authors:  J W Paterson; M E Conolly; D S Davies; C T Dollery
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

3.  Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma.

Authors:  D A Warrell; D G Robertson; J N Howes; M E Conolly; J W Paterson; L J Beilin; C T Dollery
Journal:  Br Med J       Date:  1970-01-10

4.  Primary pulmonary hypertension in a child. Response to pharmacologic agents.

Authors:  B N Satyanarayana Rao; J H Moller; J E Edwards
Journal:  Circulation       Date:  1969-10       Impact factor: 29.690

5.  Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension.

Authors:  F S Daoud; J T Reeves; D B Kelly
Journal:  Am J Cardiol       Date:  1978-11       Impact factor: 2.778

6.  Isoproterenol in pulmonary hypertension.

Authors:  M J Pelman; B L Tiep; W D Westinghouse
Journal:  N Engl J Med       Date:  1978-01-05       Impact factor: 91.245

7.  Exercise stress testing.

Authors:  M L Simoons
Journal:  N Engl J Med       Date:  1978-01-05       Impact factor: 91.245

8.  Investigation of occurrence of tolerance to bronchodilator drugs in chronically pretreated guinea-pigs.

Authors:  A A Anderson; G M Lees
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

9.  Diazoxide in treatment of primary pulmonary hypertension.

Authors:  S W Wang; J E Pohl; D J Rowlands; E G Wade
Journal:  Br Heart J       Date:  1978-05

10.  Regression of primary pulmonary hypertension.

Authors:  P D Bourdillon; C M Oakley
Journal:  Br Heart J       Date:  1976-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.